Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge
Piccicacco et al., Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkac256
https://c19early.org/piccicacco.html